I85PREP
⌘ K
ABCP Diplomate study materials
ABCP Diplomate study resources

ABCP Diplomate practice questions

One question at a time. Build your ABCP Diplomate understanding.

First 50 of 196 questions. Each one lists the choices, the correct answer, and an explanation. The checker at the top of this page saves progress in this browser when it is available.

Continue in the practice tool above to load more questions, 50 at a time.

Question 1Clinical Pharmacology

Which pharmacokinetic parameter represents the volume of plasma that would be cleared of drug per unit time?

  1. Volume of distribution
  2. Clearance Correct answer.
  3. Bioavailability
  4. Half-life

Explanation

Clearance quantifies the volume of plasma from which drug is removed per unit time and determines the maintenance dose rate needed to sustain a target concentration. Volume of distribution relates amount of drug to concentration, half-life describes the time for concentration to halve, and bioavailability describes the fraction reaching systemic circulation.

Question 2Clinical Pharmacology

A drug follows first-order elimination. If the plasma half-life is 6 hours, approximately what fraction of the steady-state concentration is reached after 24 hours of a constant infusion?

  1. About 100%
  2. About 75%
  3. About 50%
  4. About 94% Correct answer.

Explanation

Steady state is approached exponentially, with roughly 50% reached after one half-life, 75% after two, 87.5% after three, and about 94% after four half-lives. Twenty-four hours equals four half-lives, so approximately 94% of steady state is achieved.

Question 3Clinical Pharmacology

Which route of administration completely bypasses first-pass hepatic metabolism?

  1. Portal-vein infusion
  2. Oral
  3. Intravenous Correct answer.
  4. Rectal

Explanation

Intravenous administration delivers drug directly into the systemic circulation, avoiding the portal circulation and hepatic first-pass extraction. Oral and rectal routes involve partial portal absorption, and portal-vein infusion delivers drug straight to the liver.

Question 4Clinical Pharmacology

A patient on warfarin is started on rifampin. Which interaction mechanism best explains the expected change in INR?

  1. Displacement of warfarin from albumin
  2. Reduced vitamin K intake from gut flora
  3. Hepatic enzyme induction increasing warfarin metabolism Correct answer.
  4. Inhibition of CYP2C9 slowing warfarin clearance

Explanation

Rifampin is a potent inducer of hepatic cytochrome P450 enzymes and increases the metabolic clearance of warfarin, which can lower the INR and reduce anticoagulant effect. This is an enzyme-induction interaction requiring dose monitoring.

Question 5Clinical Pharmacology

Which statement correctly describes a competitive antagonist at a receptor?

  1. It shifts the agonist dose-response curve rightward without reducing maximal response Correct answer.
  2. It produces a parallel leftward shift of the agonist curve
  3. It lowers the maximal agonist response irreversibly
  4. It increases agonist potency by slowing dissociation

Explanation

A competitive antagonist binds reversibly at the same site as the agonist and can be overcome by higher agonist concentrations, producing a parallel rightward shift of the dose-response curve with unchanged maximal efficacy.

Question 6Clinical Pharmacology

A drug has a therapeutic index of 1.5. What does this value imply clinically?

  1. High oral bioavailability
  2. Wide margin of safety
  3. Complete absence of adverse effects
  4. Narrow margin between therapeutic and toxic doses Correct answer.

Explanation

Therapeutic index is the ratio of toxic dose to effective dose; a value near 1 indicates that toxic and therapeutic doses are close, requiring careful dosing and monitoring. Values far above 1 indicate a wider safety margin.

Question 7Clinical Pharmacology

Which phase of clinical drug development primarily establishes the recommended dose range and assesses efficacy in patients?

  1. Phase IV
  2. Phase II Correct answer.
  3. Phase III
  4. Phase I

Explanation

Phase II trials enroll patients with the target condition to explore efficacy and determine the appropriate dose range. Phase I focuses on safety and tolerability in small groups, Phase III confirms efficacy in larger populations, and Phase IV occurs after approval.

Question 8Clinical Pharmacology

Aminoglycosides are eliminated primarily by which route?

  1. Renal glomerular filtration Correct answer.
  2. Dermal perspiration
  3. Pulmonary exhalation
  4. Hepatic biliary excretion

Explanation

Aminoglycosides are highly polar and are eliminated largely unchanged by glomerular filtration, so renal impairment causes accumulation and increases nephrotoxicity and ototoxicity risk. Dosing therefore requires renal function adjustment.

Question 9Clinical Pharmacology

Which mechanism underlies the analgesic effect of morphine?

  1. Mu-opioid receptor agonism Correct answer.
  2. Cyclooxygenase inhibition
  3. Sodium channel blockade
  4. GABA-A receptor antagonism

Explanation

Morphine acts as an agonist at mu-opioid receptors, producing analgesia through G-protein-coupled inhibition of neuronal signaling. Cyclooxygenase inhibition describes NSAIDs, sodium channel blockade describes local anesthetics, and GABA-A antagonism describes convulsants.

Question 10Clinical Pharmacology

A patient taking an MAO inhibitor develops severe hypertension and hyperthermia after eating aged cheese. Which substance mediates this reaction?

  1. Dopamine
  2. Tyramine Correct answer.
  3. Histamine
  4. Acetylcholine

Explanation

Aged cheese contains tyramine, which is normally degraded by monoamine oxidase. When MAO is inhibited, tyramine displaces stored catecholamines and can precipitate a hypertensive crisis, the classic cheese reaction.

Question 11Clinical Pharmacology

Which adverse effect is most characteristic of chronic corticosteroid therapy?

  1. Hyperkalemia
  2. Weight loss
  3. Hypoglycemia
  4. Osteoporosis Correct answer.

Explanation

Chronic glucocorticoid excess reduces bone formation and increases resorption, leading to osteoporosis and fracture risk. Steroids also tend to cause hyperglycemia, hypokalemia, and weight gain rather than the opposite effects.

Question 12Clinical Pharmacology

A patient with reduced renal function is prescribed digoxin. Which electrolyte abnormality most increases the risk of digoxin toxicity?

  1. Hyperchloremia
  2. Hyperkalemia
  3. Hypokalemia Correct answer.
  4. Hypernatremia

Explanation

Low potassium increases digoxin binding at the sodium-potassium ATPase and enhances toxicity, so hypokalemia is a major risk factor. Hyperkalemia is more often a consequence of severe digoxin toxicity rather than its cause.

Question 13Clinical Pharmacology

Which drug is a direct inhibitor of the angiotensin-converting enzyme?

  1. Losartan
  2. Amlodipine
  3. Lisinopril Correct answer.
  4. Metoprolol

Explanation

Lisinopril inhibits angiotensin-converting enzyme, reducing angiotensin II formation and aldosterone release. Losartan blocks the angiotensin II receptor, amlodipine blocks calcium channels, and metoprolol blocks beta receptors.

Question 14Clinical Pharmacology

Which pharmacokinetic change is expected in a neonate compared with an adult?

  1. Lower total body water fraction
  2. Higher gastric acid secretion
  3. Increased glomerular filtration rate
  4. Reduced hepatic metabolic capacity Correct answer.

Explanation

Neonates have immature hepatic enzyme systems and reduced metabolic capacity, prolonging elimination of many drugs. They also have reduced glomerular filtration, lower gastric acid output, and a higher body water fraction.

Question 15Clinical Pharmacology

A drug is a weak acid with a pKa of 4. In which environment will the largest fraction be in the ionized form?

  1. Gastric fluid at pH 2
  2. Urine at pH 7 Correct answer.
  3. Plasma at pH 7.4
  4. Urine at pH 4

Explanation

For a weak acid, the fraction ionized increases as pH rises above the pKa. At pH 7, well above the pKa of 4, nearly all drug is ionized, whereas at pH values near or below the pKa the unionized fraction predominates.

Question 16Clinical Pharmacology

Which process is primarily responsible for terminating the action of acetylcholine at the neuromuscular junction?

  1. Hydrolysis by acetylcholinesterase Correct answer.
  2. Metabolism by monoamine oxidase
  3. Reuptake by presynaptic transporters
  4. Diffusion into the circulation

Explanation

Acetylcholine is rapidly hydrolyzed by acetylcholinesterase in the synaptic cleft, terminating its action. There is no significant reuptake transporter for acetylcholine, and monoamine oxidase acts on catecholamines.

Question 17Clinical Pharmacology

A patient develops muscle rigidity, hyperthermia, and altered mental status after starting an antipsychotic. Which pharmacologic mechanism best explains this syndrome?

  1. Central dopamine D2 receptor blockade Correct answer.
  2. Muscarinic receptor agonism
  3. Serotonin reuptake inhibition
  4. Beta-adrenergic stimulation

Explanation

Neuroleptic malignant syndrome is attributed to central dopamine D2 receptor blockade, producing rigidity, hyperthermia, and autonomic instability. It is distinct from serotonin syndrome, which involves serotonergic excess.

Question 18Clinical Pharmacology

Which statement about zero-order elimination is correct?

  1. Plasma concentration declines exponentially
  2. Half-life is independent of dose
  3. A constant fraction of drug is eliminated per unit time
  4. A constant amount of drug is eliminated per unit time Correct answer.

Explanation

In zero-order kinetics the elimination pathways are saturated, so a fixed amount of drug is removed per unit time regardless of concentration. This produces a linear decline in concentration and a dose-dependent half-life.

Question 19Clinical Pharmacology

Which drug interaction results from inhibition of CYP3A4 by grapefruit juice?

  1. Reduced plasma levels of a CYP3A4 inducer
  2. Decreased absorption of a CYP3A4 substrate
  3. Enhanced renal excretion of a CYP3A4 substrate
  4. Increased plasma levels of a CYP3A4 substrate Correct answer.

Explanation

Grapefruit juice inhibits intestinal CYP3A4, reducing presystemic metabolism and thereby increasing systemic exposure to CYP3A4 substrates. This can raise concentrations into the toxic range for drugs with narrow therapeutic indices.

Question 20Clinical Pharmacology

Which agent is a competitive antagonist at the nicotinic acetylcholine receptor at the neuromuscular junction?

  1. Pilocarpine
  2. Succinylcholine
  3. Neostigmine
  4. Rocuronium Correct answer.

Explanation

Rocuronium is a nondepolarizing competitive antagonist at the nicotinic receptor, blocking acetylcholine binding and producing muscle relaxation. Neostigmine inhibits acetylcholinesterase, succinylcholine is a depolarizing agonist, and pilocarpine is a muscarinic agonist.

Question 21Clinical Pharmacology

A drug is 90% bound to plasma albumin. If albumin binding is displaced by a co-administered drug, what immediate change occurs in the free drug concentration?

  1. It rises transiently Correct answer.
  2. It remains unchanged
  3. It falls to zero
  4. It falls transiently

Explanation

Displacement increases the unbound fraction, transiently raising free drug concentration and pharmacologic effect. With time, increased clearance and distribution of free drug restore a new equilibrium, so the effect may be brief unless elimination is saturated.

Question 22Clinical Pharmacology

Which laboratory finding is most consistent with severe acetaminophen overdose?

  1. Elevated transaminases with rising INR Correct answer.
  2. Hyperkalemia with peaked T waves
  3. Metabolic alkalosis with hypochloremia
  4. Elevated creatine kinase with myoglobinuria

Explanation

Acetaminophen overdose depletes glutathione, allowing the toxic metabolite NAPQI to cause centrilobular hepatic necrosis, reflected by elevated transaminases and coagulopathy with rising INR. N-acetylcysteine replenishes glutathione and is the antidote.

Question 23Clinical Pharmacology

Which principle best explains why a loading dose is administered before a maintenance infusion?

  1. To reduce the volume of distribution
  2. To saturate renal elimination pathways
  3. To rapidly achieve therapeutic concentration before steady state Correct answer.
  4. To prevent first-pass metabolism

Explanation

A loading dose fills the volume of distribution quickly so that therapeutic concentrations are reached without waiting several half-lives for accumulation. The maintenance dose then matches clearance to sustain the target concentration.

Question 24Clinical Pharmacology

Which mechanism accounts for the antihypertensive effect of amlodipine?

  1. Blockade of L-type calcium channels in vascular smooth muscle Correct answer.
  2. Activation of central alpha-2 receptors
  3. Blockade of beta-1 adrenergic receptors
  4. Inhibition of angiotensin-converting enzyme

Explanation

Amlodipine blocks L-type calcium channels in vascular smooth muscle, reducing calcium influx and causing vasodilation. Beta blockade, ACE inhibition, and central alpha-2 agonism are mechanisms of other antihypertensive classes.

Question 25Clinical Pharmacology

A drug has a high hepatic extraction ratio. Which statement about its oral bioavailability is most accurate?

  1. It is unaffected by enzyme induction
  2. It is high because hepatic clearance is rapid
  3. It is low because of extensive first-pass metabolism Correct answer.
  4. It equals its intravenous bioavailability

Explanation

For a drug with a high hepatic extraction ratio, most of the absorbed oral dose is removed during its first pass through the liver, so systemic bioavailability is low. Enzyme induction can further reduce it, and hepatic blood flow becomes a major determinant of clearance.

Question 26Clinical Pharmacology

Which route of drug administration completely avoids first-pass hepatic metabolism?

  1. Intravenous Correct answer.
  2. Sublingual
  3. Rectal
  4. Oral

Explanation

Intravenous administration delivers drug directly into the systemic circulation, bypassing the portal circulation and thus avoiding first-pass hepatic metabolism. Other routes such as oral and rectal partially enter the portal system, and sublingual avoids first-pass but is not completely reliable for all drugs.

Question 27Clinical Pharmacology

Which pharmacokinetic parameter represents the volume of plasma from which a drug is completely removed per unit time?

  1. Half-life
  2. Volume of distribution
  3. Bioavailability
  4. Clearance Correct answer.

Explanation

Clearance is defined as the volume of plasma cleared of drug per unit time. It quantifies the efficiency of drug removal by eliminating organs and is independent of the amount of drug in the body.

Question 28Clinical Pharmacology

Which receptor type is a ligand-gated ion channel that mediates rapid synaptic transmission?

  1. Nicotinic acetylcholine receptor Correct answer.
  2. Insulin receptor
  3. G protein-coupled receptor
  4. Nuclear hormone receptor

Explanation

The nicotinic acetylcholine receptor is a classic ligand-gated ion channel; acetylcholine binding opens a cation channel, producing rapid depolarization. This contrasts with slower metabotropic and nuclear signaling.

Question 29Clinical Pharmacology

Which drug is a competitive antagonist at beta-adrenergic receptors?

  1. Phenylephrine
  2. Propranolol Correct answer.
  3. Albuterol
  4. Isoproterenol

Explanation

Propranolol competitively blocks beta-adrenergic receptors, preventing catecholamine binding. The other agents are direct agonists at adrenergic receptors.

Question 30Clinical Pharmacology

Which adverse effect is most characteristic of aminoglycoside antibiotics?

  1. Hepatotoxicity
  2. Nephrotoxicity Correct answer.
  3. Pulmonary fibrosis
  4. Cardiotoxicity

Explanation

Aminoglycosides accumulate in proximal tubular cells and can cause acute kidney injury, making nephrotoxicity a hallmark adverse effect. They also cause ototoxicity, but not the other listed toxicities as characteristic effects.

Question 31Clinical Pharmacology

Which drug acts by inhibiting the enzyme cyclooxygenase and thereby reducing prostaglandin synthesis?

  1. Celecoxib
  2. Ibuprofen
  3. Aspirin Correct answer.
  4. Acetaminophen

Explanation

Aspirin irreversibly acetylates cyclooxygenase, inhibiting prostaglandin synthesis. While ibuprofen and celecoxib also inhibit COX, aspirin is the prototype and its effect is unique in being irreversible.

Question 32Clinical Pharmacology

Which statement best describes the mechanism of action of proton pump inhibitors such as omeprazole?

  1. Neutralize gastric acid directly
  2. Irreversibly inhibit the H+/K+-ATPase pump Correct answer.
  3. Stimulate prostaglandin synthesis
  4. Block histamine H2 receptors on parietal cells

Explanation

Proton pump inhibitors are prodrugs that become activated in acidic canaliculi and covalently bind to the H+/K+-ATPase, irreversibly inhibiting acid secretion. This produces prolonged suppression of gastric acid.

Question 33Clinical Pharmacology

Which vitamin deficiency is most likely to cause megaloblastic anemia?

  1. Vitamin B12 Correct answer.
  2. Vitamin C
  3. Vitamin K
  4. Vitamin D

Explanation

Vitamin B12 is required for DNA synthesis; deficiency leads to megaloblastic anemia. Folate deficiency also causes megaloblastic anemia, but folate is not listed as an option.

Question 34Clinical Pharmacology

A patient with a history of peptic ulcer disease requires an NSAID for arthritis. Which co-administered drug best reduces the risk of NSAID-induced gastric ulceration?

  1. Misoprostol Correct answer.
  2. Ranitidine
  3. Omeprazole
  4. Sucralfate

Explanation

Misoprostol, a prostaglandin E1 analog, replaces the prostaglandins whose synthesis is inhibited by NSAIDs and has been shown to reduce NSAID-induced gastric ulcers. While proton pump inhibitors are also used, misoprostol directly addresses the prostaglandin deficiency.

Question 35Clinical Pharmacology

A patient taking warfarin is prescribed an antibiotic that inhibits CYP2C9. What is the most likely clinical consequence?

  1. No change in warfarin effect
  2. Increased warfarin metabolism
  3. Decreased warfarin effect and thrombosis risk
  4. Increased warfarin effect and bleeding risk Correct answer.

Explanation

Warfarin is metabolized primarily by CYP2C9. Inhibition of this enzyme reduces warfarin clearance, raising its plasma concentration and enhancing its anticoagulant effect, which increases bleeding risk.

Question 36Clinical Pharmacology

A patient with myasthenia gravis is given a drug that blocks nicotinic acetylcholine receptors at the neuromuscular junction. Which effect is most likely?

  1. Hypertension
  2. Bradycardia
  3. Muscle weakness Correct answer.
  4. Muscle fasciculations

Explanation

Blockade of nicotinic receptors at the neuromuscular junction impairs acetylcholine-mediated muscle contraction, leading to weakness. Fasciculations would be expected with depolarizing blockers or acetylcholinesterase inhibitors, not competitive blockade.

Question 37Clinical Pharmacology

Which drug is most appropriate for immediate reversal of opioid-induced respiratory depression?

  1. Flumazenil
  2. N-acetylcysteine
  3. Atropine
  4. Naloxone Correct answer.

Explanation

Naloxone is a competitive opioid receptor antagonist that rapidly reverses opioid effects, including respiratory depression. It is the specific antidote for opioid overdose.

Question 38Clinical Pharmacology

A patient with asthma is prescribed a nonselective beta-blocker. Which adverse effect is of greatest concern?

  1. Bronchoconstriction Correct answer.
  2. Hypertension
  3. Hypoglycemia
  4. Tachycardia

Explanation

Nonselective beta-blockers block beta2 receptors in the airways, which can precipitate bronchoconstriction and asthma exacerbation. This is a major contraindication in patients with reactive airway disease.

Question 39Clinical Pharmacology

Which antibiotic mechanism is responsible for the bactericidal effect of penicillin?

  1. Inhibition of cell wall synthesis Correct answer.
  2. Inhibition of folate synthesis
  3. Inhibition of protein synthesis
  4. Disruption of DNA gyrase

Explanation

Penicillins inhibit transpeptidase enzymes involved in peptidoglycan cross-linking, weakening the bacterial cell wall and causing lysis. This is the basis of their bactericidal action against susceptible organisms.

Question 40Clinical Pharmacology

A patient taking lithium develops coarse tremor, confusion, and ataxia. Which factor is most likely to have precipitated lithium toxicity?

  1. Dehydration Correct answer.
  2. Hyperthyroidism
  3. Hyperkalemia
  4. Hyperglycemia

Explanation

Lithium is excreted renally and its reabsorption is increased in states of dehydration or sodium depletion, leading to elevated lithium levels and toxicity. The other conditions do not directly reduce lithium clearance.

Question 41Clinical Pharmacology

Which drug is a selective serotonin reuptake inhibitor (SSRI) that is also approved for premenstrual dysphoric disorder?

  1. Mirtazapine
  2. Amitriptyline
  3. Bupropion
  4. Fluoxetine Correct answer.

Explanation

Fluoxetine is an SSRI approved for major depression, obsessive-compulsive disorder, and premenstrual dysphoric disorder. The other drugs have different mechanisms or indications.

Question 42Clinical Pharmacology

A patient with a history of gout is started on a thiazide diuretic. What is the most likely effect on serum uric acid?

  1. Decreased uric acid
  2. Increased uric acid excretion
  3. Increased uric acid Correct answer.
  4. No change in uric acid

Explanation

Thiazide diuretics reduce renal uric acid excretion, leading to hyperuricemia and potentially precipitating gout. This occurs via increased proximal tubular reabsorption of urate.

Question 43Clinical Pharmacology

Which drug is a direct oral anticoagulant that selectively inhibits factor Xa?

  1. Rivaroxaban Correct answer.
  2. Dabigatran
  3. Heparin
  4. Warfarin

Explanation

Rivaroxaban directly inhibits factor Xa, thereby reducing thrombin generation. Dabigatran is a direct thrombin inhibitor, warfarin inhibits vitamin K-dependent clotting factor synthesis, and heparin enhances antithrombin activity.

Question 44Clinical Pharmacology

A patient with type 2 diabetes is prescribed metformin. Which mechanism primarily accounts for its glucose-lowering effect?

  1. Stimulation of insulin secretion
  2. Inhibition of intestinal glucose absorption
  3. Increase in insulin receptor sensitivity
  4. Reduction of hepatic gluconeogenesis Correct answer.

Explanation

Metformin decreases hepatic glucose production, primarily by reducing gluconeogenesis, and improves peripheral insulin sensitivity. It does not directly stimulate insulin secretion.

Question 45Clinical Pharmacology

A patient taking isoniazid develops peripheral neuropathy. Which vitamin deficiency is most likely responsible?

  1. Folate
  2. Vitamin B6 (pyridoxine) Correct answer.
  3. Vitamin C
  4. Vitamin B12

Explanation

Isoniazid interferes with pyridoxine metabolism, leading to vitamin B6 deficiency and peripheral neuropathy. Supplementation with pyridoxine prevents this adverse effect.

Question 46Clinical Pharmacology

A patient requires a drug that is a potent inhibitor of the cytochrome P450 enzyme CYP3A4. Which drug should be avoided to prevent increased levels of co-administered CYP3A4 substrates?

  1. Rifampin
  2. Carbamazepine
  3. Ketoconazole Correct answer.
  4. Phenobarbital

Explanation

Ketoconazole is a strong inhibitor of CYP3A4 and can significantly raise plasma concentrations of drugs metabolized by this enzyme. The other agents are enzyme inducers and would decrease substrate levels.

Question 47Clinical Pharmacology

A patient with a history of angle-closure glaucoma is prescribed a drug. Which class of drugs is most likely to precipitate acute angle-closure glaucoma?

  1. Carbonic anhydrase inhibitors
  2. Muscarinic antagonists Correct answer.
  3. Alpha-adrenergic agonists
  4. Beta-blockers

Explanation

Muscarinic antagonists such as atropine cause mydriasis, which can narrow the anterior chamber angle and precipitate acute angle-closure glaucoma in susceptible individuals. The other drug classes either lower intraocular pressure or have no significant mydriatic effect.

Question 48Clinical Pharmacology

A patient with a history of heart failure is started on a drug that inhibits the sodium-glucose cotransporter 2 (SGLT2). Which beneficial effect on heart failure is most likely?

  1. Direct positive inotropic effect
  2. Increase in myocardial oxygen demand
  3. Increase in heart rate
  4. Reduction in preload and afterload Correct answer.

Explanation

SGLT2 inhibitors promote natriuresis and diuresis, reducing preload, and may also reduce afterload through effects on vascular function. These hemodynamic effects contribute to their benefit in heart failure.

Question 49Clinical Pharmacology

A patient with bipolar disorder is maintained on lithium. Which laboratory monitoring parameter is most important to assess for long-term therapy?

  1. Pancreatic enzymes
  2. Liver function
  3. Thyroid-stimulating hormone
  4. Renal function Correct answer.

Explanation

Lithium is eliminated by the kidneys and can cause nephrogenic diabetes insipidus and chronic interstitial nephritis, so renal function must be monitored regularly. Thyroid function is also monitored, but renal function is critical for safe dosing and toxicity prevention.

Question 50Clinical Pharmacology

A patient taking clopidogrel is found to have reduced platelet inhibition. Which genetic polymorphism most likely explains this?

  1. CYP2D6 ultrarapid metabolism
  2. HLA-B*5701
  3. G6PD deficiency
  4. CYP2C19 loss-of-function Correct answer.

Explanation

Clopidogrel is a prodrug requiring activation by CYP2C19. Loss-of-function polymorphisms in CYP2C19 reduce formation of the active metabolite, leading to diminished antiplatelet effect.